Tags

Type your tag names separated by a space and hit enter

Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Eur Neurol 1983; 22 Suppl 1:105-7EN

Abstract

The influence of pentoxifylline (11-18 mg/kg orally, Trental 400) on impaired hemorheologic conditions has been investigated in a total of 73 patients with CVI. Throughout a treatment period of 4 weeks, there was a significant improvement in red cell behavior and a significant inhibition of increased platelet aggregation; moreover, a fall in plasma fibrinogen and of blood viscosity has also been observed.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

6884401

Citation

Ott, E, et al. "Hemorheological Effects of Pentoxifylline On Disturbed Flow Behavior of Blood in Patients With Cerebrovascular Insufficiency." European Neurology, vol. 22 Suppl 1, 1983, pp. 105-7.
Ott E, Lechner H, Fazekas F. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency. Eur Neurol. 1983;22 Suppl 1:105-7.
Ott, E., Lechner, H., & Fazekas, F. (1983). Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency. European Neurology, 22 Suppl 1, pp. 105-7.
Ott E, Lechner H, Fazekas F. Hemorheological Effects of Pentoxifylline On Disturbed Flow Behavior of Blood in Patients With Cerebrovascular Insufficiency. Eur Neurol. 1983;22 Suppl 1:105-7. PubMed PMID: 6884401.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency. AU - Ott,E, AU - Lechner,H, AU - Fazekas,F, PY - 1983/1/1/pubmed PY - 1983/1/1/medline PY - 1983/1/1/entrez SP - 105 EP - 7 JF - European neurology JO - Eur. Neurol. VL - 22 Suppl 1 N2 - The influence of pentoxifylline (11-18 mg/kg orally, Trental 400) on impaired hemorheologic conditions has been investigated in a total of 73 patients with CVI. Throughout a treatment period of 4 weeks, there was a significant improvement in red cell behavior and a significant inhibition of increased platelet aggregation; moreover, a fall in plasma fibrinogen and of blood viscosity has also been observed. SN - 0014-3022 UR - https://www.unboundmedicine.com/medline/citation/6884401/Hemorheological_effects_of_pentoxifylline_on_disturbed_flow_behavior_of_blood_in_patients_with_cerebrovascular_insufficiency_ L2 - https://www.karger.com?DOI=10.1159/000115658 DB - PRIME DP - Unbound Medicine ER -